Abstract
Streptococcus suis serotype 2 (SS 2) is an important zoonotic pathogen that has caused two major infectious outbreaks of streptococcal toxic shock syndrome (STSS) in China. A novel gene located in the 89K pathogenicity island (PAI) encoding a putative hemolysin-III-related protein (Hhly3) has been previously characterized. In this study, the SS2 deletion mutant of the exogenous gene hhly3 was constructed by homologous recombination. This protein was found to exhibit cytolytic activity, and hemolytic activity of the hhly3 gene knockout mutant (Δhhly3) was significantly lower than that in the wild-type strain ZY05719. In addition, qRT-PCR revealed that Hhly3 played an important role in the expression of the secreted hemolysin SLY, which may be the key reason for the decreased hemolytic activity. Consequently, compared with the WT strain, the infection and pathogenicity of Δhhly3 was also decreased, as evidenced by in vitro bacterial growth in whole blood and by the in vivo zebrafish test, suggesting that hhly3 is a novel exogenous hemolysis-related gene in SS2 strains.
Introduction
Streptococcus suis is a pathogen that is responsible for a variety of life-threatening infections in pigs and humans worldwide. Among the 33 known S . suis serotypes, S . suis serotype 2 (SS 2) is one of the most virulent and frequently isolated serotypes [1]. In particular, two major emerging human SS2 outbreaks in China (in 1998 and 2005), which mainly featured streptococcal toxic shock syndrome (STSS), indicated the emergence of new virulent streptococcal variants in China [2]. In our previous study, suppression subtractive hybridization (SSH) was employed to study the virulence factors of SS2 [3]. More than one-third of the hypothetical virulence fragments, including a specific fragment (SSU05_0925), were found to be associated with the candidate pathogenicity island (PAI) termed 89K [4]. This novel gene encoded a protein containing 8 N-terminal transmembrane domains. As the 328-432 aa transmembrane domains were relatively conserved in the integral membrane protein superfamily hemolysin-III (cl03831), this hypothetical protein was represented by the abbreviation Hhly3. Data published to date indicate that the prokaryotic members of the Hly-III family are expressed in many species and that they induce cytolysis of eukaryotic cells via three steps of pore formation [5]. Multiple sequence alignments revealed that Hhly3 showed considerable homology with TrbL/VirB6 plasmid conjugal transfer protein (pfam04610), which was one of the components of type IV secretion system (T4SS) [6]. In this study, an hhly3 deletion mutant of the Chinese virulent strain ZY05719 was constructed by homologous recombination to determine the role of this putative exogenous gene in hemolysis and other virulence-related functions of SS2.
Materials and Methods
Ethics
All animal experimental protocols were approved by approved by the Ethics Committee of Veterinary Institute Jiangsu Academy of Agricultural Sciences (No.SYXK 2010-0005) and performed accordingly. All efforts were made to minimize animals’ suffering.
Bacterial strains, plasmids, and growth conditions
The bacteria strains and plasmids used in the present study are listed in Table 1 and Table 2. SS2 strains (e.g. ZY05719) were grown in Todd-Hewitt broth (THB, Oxoid) liquid medium and plated on THB agar plates containing 5% (v/v) sheep blood. E. coli strains were grown in Luria broth (LB, Oxoid) and plated on LB agar plates. When required, antibiotics were added to the medium at the following concentrations: 100 µg/mL of spectinomycin (Sigma) for the SS2 mutant strain and 100 µg/mL of spectinomycin and 100 µg/mL of ampicillin (Sigma) for E. coli.
Table 1. Characteristics of the bacterial strains, plasmids, and primers used in this study.
Strain, Plasmid and primer | Relevant characteristics a or sequence (5′- 3′)b | Source or reference | |
---|---|---|---|
Strains | |||
ZY05719 | Virulent strain isolated from diseased pigs in Sichuan province in 2005 | Lab collection | |
Δhhly3 | Isogenic hhly3 mutant of strain ZY05719 | This study | |
CΔhhly3 | Complemented strain of hhly3; Spc R | This study | |
E. coli DH5α | Host for cloning vector | Invitrogen | |
E. coli BL21 (DE3) | For expressing the recombinant plasmids | Invitrogen | |
Plasmid | |||
pSET4s | S . suis thermosensitive suicide vector; Spc R | Takamatsu (2001) | |
pSET4s: :hhly3 | A recombinant vector with the background of pSET4s, designed to knockout hhly3; Spc R | This study | |
pSET2 | E. coli- S . suis shuttle vector; Spc R | Takamatsu (2001) | |
pSET2: :hhly3 | pSET2 containing the intact hhly3 gene and its upstream promoter; Spc R | This study | |
Primer | |||
CDS1 | GTGAAACCATCAATAGTAAA | Analyze distribution of the hhly3 gene | This study |
CDS2 | TCATGGTTTCTTACCGACTT | ||
RH1 | CGGAATTC GTGACCTTTGCAGGAATCTA | Truncated fragment of hhly3 | This study |
RH2 | CCCTCGAG ATGGTTTCTTACCGACTTTC | ||
LA1 | AA CTGCAG TTGTAATGGAATCAAC | Upstream border of hhly3 | This study |
LA2 | GC GTCGAC AGTTGAAAACTTTAGT | ||
RA1 | CG GGATCC ATTTACACCTCTTTTCGCA | Downstream border of hhly3 | This study |
RA2 | CC CCCGGG CTACCAGCAACAGCAATT | ||
IN-F | GTTGAAATACTAAATGCTGT | Internal region of hhly3 | This study |
IN-R | ACATTAAAAAAATCAATGAC | ||
OUT-F | CAGCTTGTGCTTCCGATAGTGG | For combined PCR detection | This study |
OUT-R | CTTTGGGATTCCTGTGGCTTTC | ||
hhly3C-F | CGGATCC TTCCGCTGTCCTGTTCATCT | hhly3 gene and its upstream promoter | This study |
hhly3C-R | GCTGCAG CAATCAGAAGCGATTGCGTG | ||
SLY1 | TCATTCAGGTGCTTATGTTGCG | Analyze the expression profiling of sly gene | This study |
SLY2 | GAAGATTGCGAGCATTTCCTGG |
a Spc R, spectinomycin resistance
b Underlined nucleotides denote enzyme restriction sites.
Distribution of hhly3 in S . suis strains and localization of Hhly3
The isoelectric point (pI) and molecular weight (Mw) were predicted using DNAStar software. Primers were designed according to the open reading frame (ORF) to analyze the distribution of hhly3 in S . suis strains by PCR (Table 1).
In a previous study, the shhly3 gene encoding the recombinant truncated protein Hhly3 was amplified using the primers RH1/RH2 (Table 1). The recombinant plasmid pET32a(+)::shhly3 was transformed into E. coli BL21 (DE3) for the expression of the recombinant protein rsHhly3. In addition, the immunogenicity of HisTrap-purified rsHhly3 was analyzed, and anti-rsHhly3 rabbit polyclonal antibody was prepared. In the previous study, Hhly3 was absent in the culture supernatant as well as in the cell wall of the wild-type (WT) strain ZY05719. In this study, the membrane-associated proteins of ZY05719 and its mutants were prepared according to the Triton X-114 extraction protocol [7]. The membrane-associated proteins were detected by Western blot analysis using rabbit polyclonal antibodies to rsHhly3 to determine the localization of Hhly3.
Deletion and functional complementation of hhly3
DNA fragments were PCR amplified from the chromosomal DNA of ZY05719 using two pairs of Hhly3-specific primers, LA1/LA2 and RA1/RA2 (Table 1). The fragments were directionally cloned into the temperature-sensitive S . suis -E. coli shuttle vector pSET4s [8] to generate the hhly3 knockout vector pSET4s::hhly3. Procedures for the selection of mutants by allelic exchange via double crossover have been described previously [9]. ZY05719 containing the pSET4s::hhly3 vector was grown at 28°C in the presence of spectinomycin before screening for the clones both vector-loss and exchanged the wild type allele hhly3 via a double cross-over homologous recombination at 37°C. The resulting Δhhly3 mutant strain was verified by PCR amplification using the primer pairs IN1/IN2 and OUT1/OUT2 (Figure 1A).
For complementation assays, a DNA fragment containing the entire hhly3 gene and promoter sequence was cloned into the E. coli- S . suis shuttle vector pSET2 [10] to generate the hhly3-complementing plasmid pSET2::hhly3. The functional complement strain Δhhly3 (CΔhhly3) carrying this plasmid was obtained by selective growth in the presence of spectinomycin.
Hemolysin activity assay
SS2 strains were cultured on sheep blood agar plates incubated in a candle jar to create anoxic conditions. Hemolysin activity was tested as previously described [11]. Briefly, sterile culture supernatants or cell product following ultrasonication were prepared from bacterial cultures and centrifuged to separate the culture supernatant fluids and cell pellets. The sonicated cell pellets were suspended in cold phosphate-buffered saline (PBS; pH 7.0) to obtain bacterial protein. Serial twofold dilutions (150 µL) of the test samples were prepared in 96-well microplates. Approximately 150 µL of 1% sheep erythrocyte suspension was added to THB broth. After incubation for 2 h at 37°C, the microplates were centrifuged at 5,000g for 10 min, and 150 µL of the supernatant was transferred to a new plate for spectrophotometric measurements at 540 nm. Hemolysin units (HU) were defined as the reciprocal of the highest dilution of supernatant inducing at least 50% lysis of erythrocytes. The hemolytic activities of culture supernatant fluids during various growth phases were also observed.
SLY RNA manipulation and qRT-PCR
Total RNA was extracted from the bacterial culture at various growth phases by using the TRIZOL reagent [12]. cDNAs were created by reverse transcription with PrimeScript RT-PCR kit (Takara). The specific primers SLY1/SLY2 of the hemolysin gene sly are shown in Table 1. The relative change in the gene expression ratios of the selected genes was normalized to the expression of a single housekeeping gene (16S rRNA gene). Subsequently, the SYBR Premix Ex Taq kit (Takara Bio) was used for semi-quantitative RT-PCR assay, and the mRNA levels was analyzed by the comparative cycle threshold method (2 –ΔΔCT method) [13].
Survival in the presence of swine whole blood
Blood samples were collected from healthy pigs by venous puncture. Susceptibility assays were performed as previously described [14]. WT, Δhhly3, and CΔhhly3 were cultured to OD600 = 0.4–0.6, and the cells were pelleted and suspended in THB medium to obtain an OD600 of 0.1. The whole blood, pig serum, and SS2 cell mixture was incubated for 3 h at 37°C with occasional gentle shaking. Infected whole blood cultures were harvested at 0 and 3 h to determine bacterial growth using the plate count method. The first time point (0 h) was considered as the 100% viability control.
Animal infections
The use of zebrafish as an infection model for S . suis has been accepted by the World Organization for Animal Health (OIE) [15]. Zebrafish were assigned to six groups, with 15 zebrafish per group. As a matter of fact, the median lethal dose (LD50) should be ascertained to determine the differences in virulence between the WT and mutant strains. The SS2 strain was cultured to the logarithmic growth phase, then adjusted to 5 × 109 CFU/mL and serially diluted tenfold until the lowest concentration of 5 × 104 CFU/mL was reached. These three SS2 strains were injected intraperitoneally at a concentration of 0.01 mL into the zebrafish. The mortality of the zebrafish was recorded, and the LD50 value was calculated according to Karber [16].
Statistical analysis
All assays were performed in triplicate. Statistical analyses were carried out using the GraphPad Software package. Where appropriate, the data were analyzed using Student’s t test. The non-parametric Mann-Whitney U test was used for the analysis of the animal infection study. A P value of <0.05 was considered statistically significant and P < 0.01 was considered highly statistically significant.
Results
Distribution of hhly3 in S . suis strains and localization of Hhly3
The hhly3 gene was located at 896463–898574 bp on the complementary strand of the ZY05719 genome, and it encoded a hypothetical protein with a predicted molecular mass of 78 kDa and a pI of 9.82. PCR analysis of hhly3 distribution revealed that this gene was present in most Chinese SS2 isolates, especially those isolated from the regions surrounding the two large outbreak areas, but the gene was not present in the avirulent strain T15 and in other European virulent isolates such as P1/7 (Table 2). This result was also consistent with the detection result of 89K PAI, suggesting that the hhly3 gene is an exogenous gene of SS2.
Table 2. Distribution of the hhly3-specific DNA fragments.
Strain | Serotype or species | Sourcea | hhly3 | 89K PAI |
---|---|---|---|---|
BA853 | SS2 | ATCCa | - | - |
700794 | SS2 | Canada, ATCCa | - | - |
P1/7 | SS2 | Netherlands, ATCCa | - | - |
T15 | SS2 | Netherlands, ATCCb | - | - |
JDZ05802-2 | SS2 | Jiangxia | + | + |
191 | SS2 | Sichuanc | + | + |
ZY05721 | SS2 | Sichuana | + | + |
ZY05719 | SS2 | Sichuana | + | + |
SS2-H | SS2 | Jiangsua | + | + |
HA9801 | SS2 | Jiangsua | + | + |
59A | SS2 | Shanghaia | + | + |
159E | SS2 | Shanghaia | + | + |
97A | SS2 | Zhejianga | - | - |
JR05730 | SS2 | Jiangsua | + | + |
S50 | SS2 | Guangdonga | - | - |
88B | SS2 | Guangdonga | + | + |
227 | SS2 | Sichuanc | + | + |
98012 | SS2 | Jiangsuc | + | + |
XT | SS2 | Hunana | + | + |
HA | SS2 | Jiangsua | + | + |
05464 | SS2 | Sichuana | + | + |
SH28 | SS1 | Shanghaia | - | - |
SH13 | SS10 | Shanghaib | - | - |
DL15 | SS10 | Sichuanb | - | - |
NP4 | SS12 | Na | - | - |
AH091106 | SS11 | Anhuia | - | - |
26S1 | SS1/2 | Canadaa | - | - |
SS9-2083 | SS9 | Shanghaib | - | - |
SH06 | SS9 | Na | - | - |
SH59 | SS9 | Shanghaia | - | - |
SH65 | SS7 | Guangdonga | - | - |
SH04805 | SS7 | Shanghaia | - | - |
a Strains were isolated from diseased pigs.
b Strains were isolated from healthy pigs.
c Strains were isolated from diseased human.
Moreover, Western blot analysis of Hhly3 showed that this protein was localized in the membrane of ZY05719 (Figure 1B). As it was absent both in the culture supernatant as well as in the cell wall and its multiple transmembrane domains, we inferred that it may be a membrane channel protein.
Construction and characterization of an hhly3-defective mutant
An isogenic hhly3 mutant of the WT strain ZY05719 was constructed through homologous recombination. The double-crossover event was confirmed by multiple PCR (Figure 1C) and direct DNA sequencing (data not shown), verifying that an isogenic knockout mutant of hhly3 (namely Δhhly3) was successfully constructed without alteration of the remaining sequences.
Deletion of hhly3 decreases the hemolytic activity of S . suis
In order to study the hemolytic activity of Hhly3, the hhly3-complementing plasmid pSET2::hhly3 was transformed into BL21 (DE3), the commercially available competent E. coli strain. The hemolytic activity of the bacterial protein harvested by ultrasonication was measured. The bacterial protein of pSET2::hhly3 BL21 had significantly higher (P < 0.01) hemolytic activity than BL21 (pSET2; Figure 2A), suggesting that Hhly3 is a hemolytic protein.
In addition, we compared the hemolytic activities of the SS2 mutant strains. Different SS2 strains were inoculated on sheep blood agar plates and incubated in anoxic conditions, and the α-hemolytic zones created by the Δhhly3 strain were slightly smaller than those created by the WT strain. Consequently, the hemolytic activity of the supernatant and protein fraction of the Δhhly3 mutant was significantly lower (P < 0.01) than that in the hhly3 strain, and this activity was subsequently restored in CΔhhly3 (Figure 2A). In general, the hemolysis mainly occurred in the supernatant in the SS2 strain as the hemolytic activities of bacterial proteins were much poorer than those of the culture supernatant (Figure 2A). Furthermore, the effects of hhly3 inactivation on the hemolytic activities of bacterial proteins were also lower than in the supernatants (Figure 2A).
Considering differences in the hemolytic activities during various growth phases, the late logarithmic phase to stationary phase was considered suitable for determining the hemolytic activity. In the stationary phase (OD600 = 1.0–1.3), the highest dilution of culture supernatants that induced at least 50% lysis of erythrocytes for the ZY05719, Δhhly3, and CΔhhly3 strains were 1:128, 1:32, and 1:128, respectively (Figure 2B). In terms of cell growth, the difference between the Δhhly3 mutant and the WT strain increased in significance till the stationary phase was reached (Figure 2C).
Expression profiling of the sly gene
The expression profile of sly encoding the known secreted hemolysin was analyzed in SS2 strains in vitro by qRT-PCR. Equal amounts of total RNA were reverse-transcribed from different growth phases. The expression of sly exhibited the same variation as hemolytic activity of culture supernatants (Figure 2d). Compared with the WT strain, the mRNA levels of sly in the late logarithmic phase was significantly decreased by 76% in the Δhhly3 mutant (P < 0.05).
Decreased susceptibility in whole blood
As shown in Figure 3, Δhhly3 had a higher death rate in the whole pig blood in vitro than WT strain and the complementation strain CΔhhly3 (P < 0.01). After 3 h of incubation, the survival rates of ZY05719, Δhhly3, and CΔhhly3 were 30.4%, 46.8%, 39.7%, respectively, indicating that the resistance of the pathogen to phagocytosis and killing in whole blood decreased by hhly3 inactivation.
Virulence attenuation by hhly3 inactivation
The effect of the hhly3 gene in virulence was evaluated in the zebrafish model by intraperitoneal administration of various doses of ZY05719, Δhhly3, and CΔhhly3. The mortality of zebrafish was observed within 7 days after the challenge. As shown in Table 3, the LD50 was 2.39 × 105 1.30 × 106, and 4.23 × 105 CFU/zebrafish for the WT, Δhhly3, and CΔhhly3 strains, respectively (P < 0.05).
Table 3. Calculation of LD50 for the ZY05719 strain, mutants, and complemented strain in zebrafish.
Challenge dose (CFU) | Zebrafish numbers | Death numbers a
|
||
---|---|---|---|---|
ZY05719 | Δhhly3 | CΔhhly3 | ||
5×107 | 15 | 15.0 ± 0.0 | 15.0 ± 0.0 | 15.0 ± 0.0 |
5×106 | 15 | 14.0 ± 1.0 | 10.7 ±1.2 | 13.3 ± 0.6 |
5×105 | 15 | 9.3 ± 1.2 | 4.7 ±1.2 | 8.7 ± 0.6 |
5×104 | 15 | 3.3 ± 0.6 | 1.0 ± 1.0 | 1.7 ±0.6 |
5×103 | 15 | 0.7 ± 0.6 | 0.0 ± 0.0 | 0.0 ± 0.0 |
5×102 | 15 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
Value of LD50 (×105) | 2.39 ± 0.21 | 12.97 ± 1.10b | 4.23 ± 0.71b |
a Values are means ± Standard deviations (three samples per group)
b Significantly different (P < 0.05) from value for WT strain group as calculated by the non-parametric Mann-Whitney U test
Discussion
Hemolytic activity is a phenotypic marker used to distinguish between highly virulent and avirulent isolates. Thus far, bacterial hemolysin can be categorized into many types, including the cholesterol-binding cytolysin family and repeats in toxin (RTX) family. This study confirmed that Hhly3 possesses hemolytic activity. The hemolytic activity of the Δhhly3 mutant was significantly lower than that of the WT strain; however, it did not completely disappear.
This study indicated that SS2 hemolysis was largely dependent on the cytolysis activity of secretory proteins, especially the dominant hemolysin SLY. The characteristics of SLY are clear: this secreted protein had higher expression and secretion levels as well as greater stability in the late logarithmic phase [17,18]. It is noteworthy that as an exotoxin, SLY should be exposed in time after the expression reducing the risk of toxicity to donor bacteria. Hhly3, which has been verified to be a hemolytic membrane channel protein, was considerable to have homology with a component in T4SS for protein secretion [19]. In this study, the low expression of SLY achieved by hhly3 inactivation was in compliance with the negative regulation to block the secretion of SLY. Therefore, we have reason to speculate that hhly3 inactivation may block of the secretory pathways of SLY, causing imbalance of expression and secretion. Therefore, the expression level of SLY was reduced to ensure the survival of bacteria, and the hemolytic activity of SS2 was greatly decreased. In addition, we found that the European virulent isolate P1/7, which lacked 89K PAI, showed considerably higher degree of hemolysis while carrying the pSET2::hhly3 plasmid, indicating that Hhly3 was one of the important factors of cytolysis.
Furthermore, SLY-positive strains seem to additionally benefit from the toxic effects of this hemolysin for polymorphonuclear neutrophil (PMNs) and could better survive in blood [20]. The susceptibility of Δhhly3 in pig blood decreased mainly due to the lower expression of SLY, which might account partially for the virulence loss in Δhhly3 in zebrafish infection. However, Hhly3 might be also related to the secretion of some extracellular proteins relevant to colonization and immune escape, although additional studies are require to confirm this assumption.
89K PAI is a novel mosaic PAI candidate that is prevalent and unique in Chinese SS2 virulent strains. Since the discovery of this PAI, multiple virulence factors have been characterized [21,22]. This study showed that the putative exogenous gene, hhly3, was in 89K PAI and expressed successfully, strongly suggesting that this PAI is responsible for the great variation in the virulence of strain SS2, resulting in high casualties during the two outbreaks of STSS. During the infection of SS2, the WT strain carrying the hhly3 gene was more significant in infection. More importantly, this hemolytic protein played an important role in expression of the major hemolysis factor SLY, causing considerably greater damage to the host cell.
Funding Statement
This study was supported by the Program from the National Basic Research Program (973) of China (2012CB518804), the National Natural Science Foundation of China (31172319), the Key Technology R&D Program of Jiangsu (BE2009388), the Fundamental Research Funds for the Central Universities (KYT 201003), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Higgins R, Gottschalk M (2000) Distribution of Streptococcus suis capsular types in 1999. Can Vet J 41: 414 PubMed: 10816840. [PMC free article] [PubMed] [Google Scholar]
- 2. Tang J, Wang C, Feng Y, Yang W, Song H et al. (2006) Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLOS Med 3: e151. doi:10.1371/journal.pmed.0030151. PubMed: 16584289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Jiang H, Fan HJ, Lu CP (2009) Identification and distribution of putative virulent genes in strains of Streptococcus suis serotype 2. Vet Microbiol 133: 309-316. doi:10.1016/j.vetmic.2008.07.014. PubMed: 18762393. [DOI] [PubMed] [Google Scholar]
- 4. Chen C, Tang J, Dong W, Wang C, Feng Y et al. (2007) A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLOS ONE 2: e315. doi:10.1371/journal.pone.0000315. PubMed: 17375201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Chen YC, Chang MC, Chuang YC, Jeang CL (2004) Characterization and virulence of hemolysin III from Vibrio vulnificus. Curr Microbiol 49: 175-179. PubMed: 15386100. [DOI] [PubMed] [Google Scholar]
- 6. Jakubowski SJ, Krishnamoorthy V, Cascales E, Christie PJ (2004) Agrobacterium tumefaciens VirB6 domains direct the ordered export of a DNA substrate through a type IV secretion System. J Mol Biol 341: 961-977. doi:10.1016/j.jmb.2004.06.052. PubMed: 15328612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Zhang W, Lu CP (2007) Immunoproteomic assay of membrane-associated proteins of Streptococcus suis type 2 China vaccine strain HA9801. Zoonoses. Public Health 54: 253-259. [DOI] [PubMed] [Google Scholar]
- 8. Takamatsu D, Osaki M, Sekizaki T (2001) Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid 46: 140-148. doi:10.1006/plas.2001.1532. PubMed: 11591139. [DOI] [PubMed] [Google Scholar]
- 9. Wu T, Chang H, Tan C, Bei W, Chen H (2009) The orphan response regulator RevSC21 controls the attachment of Streptococcus suis serotype-2 to human laryngeal epithelial cells and the expression of virulence genes. FEMS Microbiol Lett 292: 170-181. doi:10.1111/j.1574-6968.2008.01486.x. PubMed: 19210676. [DOI] [PubMed] [Google Scholar]
- 10. Takamatsu D, Osaki M, Sekizaki T (2001) Construction and characterization of Streptococcus suis-Escherichia coli shuttle cloning vectors. Plasmid 45: 101-113. doi:10.1006/plas.2000.1510. PubMed: 11322824. [DOI] [PubMed] [Google Scholar]
- 11. Zheng F, Ji H, Cao M, Wang C, Feng Y et al. (2011) Contribution of the Rgg transcription regulator to metabolism and virulence of Streptococcus suis serotype 2. Infect Immun 79: 1319-1328. doi:10.1128/IAI.00193-10. PubMed: 21149588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Ampe F, ben Omar N, Guyot JP (1998) Recovery of total microbial RNA from lactic acid fermented foods with a high starch content. Lett Appl Microbiol 27: 270-274. [DOI] [PubMed] [Google Scholar]
- 13. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609. [DOI] [PubMed] [Google Scholar]
- 14. Zhu H, Huang D, Zhang W, Wu Z, Lu Y et al. (2011) The novel virulence-related gene stp of Streptococcus suis serotype 9 strain contributes to a significant reduction in mouse mortality. Microb Pathog 51: 442-453. doi:10.1016/j.micpath.2011.08.002. PubMed: 21924346. [DOI] [PubMed] [Google Scholar]
- 15. OIE. Available: http://web.oie.int/eng/info/hebdo/AIS_54.HTM. Accessed 2013 August 9.
- 16. Sánchez-Vázquez FJ, Terry MI, Felizardo VO, Vera LM (2011) Daily rhythms of toxicity and effectiveness of anesthetics (MS222 and eugenol) in zebrafish (Danio rerio). Chronobiol Int 28: 109-117. doi:10.3109/07420528.2010.538105. PubMed: 21231872. [DOI] [PubMed] [Google Scholar]
- 17. Xu L, Huang B, Du H, Zhang XC, Xu J et al. (2010) Crystal structure of cytotoxin protein suilysin from Streptococcus suis. Protein Cell 1: 96-105. doi:10.1007/s13238-010-0012-3. PubMed: 21204001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Tan C, Liu M, Jin M, Liu J, Chen Y et al. (2008) The key virulence-associated genes of Streptococcus suis type 2 are upregulated and differentially expressed in vivo. FEMS Microbiol Lett 278: 108-114. doi:10.1111/j.1574-6968.2007.00980.x. PubMed: 18005162. [DOI] [PubMed] [Google Scholar]
- 19. Villamil Giraldo AM, Sivanesan D, Carle A, Paschos A, Smith MA et al. (2012) Type IV secretion system core component VirB8 from Brucella binds to the globular domain of VirB5 and to a periplasmic domain of VirB6. Biochemistry 51: 3881-3890. doi:10.1021/bi300298v. PubMed: 22515661. [DOI] [PubMed] [Google Scholar]
- 20. Chabot-Roy G, Willson P, Segura M, Lacouture S, Gottschalk M (2006) Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb Pathog 41: 21-32. doi:10.1016/j.micpath.2006.04.001. PubMed: 16714092. [DOI] [PubMed] [Google Scholar]
- 21. Li M, Wang C, Feng Y, Pan X, Cheng G et al. (2008) SalK/SalR, a two-component signal transduction system, is essential for full virulence of highly invasive Streptococcus suis serotype 2. PLOS ONE 3: e2080. doi:10.1371/journal.pone.0002080. PubMed: 18461172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Feng Y, Zhang H, Ma Y, Gao GF (2010) Uncovering newly emerging variants of Streptococcus suis, an important zoonotic agent. Trends Microbiol 18: 124-131. doi:10.1016/j.tim.2009.12.003. PubMed: 20071175. [DOI] [PubMed] [Google Scholar]